These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29624477)

  • 1. The immunization status of children with chronic neurological disease and serological assessment of vaccine-preventable diseases.
    Dinleyici M; Carman KB; Kilic O; Laciner Gurlevik S; Yarar C; Dinleyici EC
    Hum Vaccin Immunother; 2018; 14(8):1970-1976. PubMed ID: 29624477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination Coverage by Age 24 Months Among Children Born in 2015 and 2016 - National Immunization Survey-Child, United States, 2016-2018.
    Hill HA; Singleton JA; Yankey D; Elam-Evans LD; Pingali SC; Kang Y
    MMWR Morb Mortal Wkly Rep; 2019 Oct; 68(41):913-918. PubMed ID: 31622284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination Coverage by Age 24 Months Among Children Born in 2016 and 2017 - National Immunization Survey-Child, United States, 2017-2019.
    Hill HA; Yankey D; Elam-Evans LD; Singleton JA; Pingali SC; Santibanez TA
    MMWR Morb Mortal Wkly Rep; 2020 Oct; 69(42):1505-1511. PubMed ID: 33090985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against vaccine preventable diseases in children treated for acute lymphoblastic leukemia.
    de de la Fuente Garcia I; Coïc L; Leclerc JM; Laverdière C; Rousseau C; Ovetchkine P; Tapiéro B
    Pediatr Blood Cancer; 2017 Feb; 64(2):315-320. PubMed ID: 27718310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization coverage and timeliness of vaccination in Italian children with chronic diseases.
    Pandolfi E; Carloni E; Marino MG; Ciofi degli Atti ML; Gesualdo F; Romano M; Giannattasio A; Guarino A; Carloni R; Borgia P; Volpe E; Perrelli F; Pizzuti R; Tozzi AE
    Vaccine; 2012 Jul; 30(34):5172-8. PubMed ID: 21414380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-appropriate versus up-to-date coverage of routine childhood vaccinations among young children in Israel.
    Stein-Zamir C; Israeli A
    Hum Vaccin Immunother; 2017 Sep; 13(9):2102-2110. PubMed ID: 28696824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence and vaccination coverage of vaccine-preventable diseases in perinatally HIV-1-infected patients.
    Sticchi L; Bruzzone B; Caligiuri P; Rappazzo E; Lo Casto M; De Hoffer L; Gustinetti G; Viscoli C; Di Biagio A
    Hum Vaccin Immunother; 2015; 11(1):263-9. PubMed ID: 25483544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The new National Immunization Program 2017-2019 and the Essential Care Levels: what is going to change?].
    De Waure C; Sisti LG; Poscia A; Ricciardi W
    Ig Sanita Pubbl; 2017; 73(5):405-418. PubMed ID: 29433128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Today's vaccination policies in Italy: The National Plan for Vaccine Prevention 2017-2019 and the Law 119/2017 on the mandatory vaccinations.
    Di Pietro A; Visalli G; Antonuccio GM; Facciolà A
    Ann Ig; 2019; 31(2 Supple 1):54-64. PubMed ID: 30994164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunization coverage of children aged 0 to 5 years in Libreville (Gabon)].
    Ategbo S; Ngoungou EB; Koko J; Vierin Y; Zang Ndong CE; Moussavou Mouyama A
    Sante; 2010; 20(4):215-9. PubMed ID: 21266317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
    Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
    Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National and state vaccination coverage among children aged 19-35 months--United States, 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Sep; 60(34):1157-63. PubMed ID: 21881546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of immunity status to routine vaccination in pediatric liver transplant candidates.
    Dehghani SM; Shakiba MA; Ziaeyan M; Imanieh MH; Haghighat M; Sedaghat M; Alborzi A; Malek-Hosseini SA
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():26-31. PubMed ID: 25910330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety of a combined measles, mumps, rubella and varicella live vaccine (ProQuad ®) administered concomitantly with a booster dose of a hexavalent vaccine in 12-23-month-old infants.
    Deichmann KA; Ferrera G; Tran C; Thomas S; Eymin C; Baudin M
    Vaccine; 2015 May; 33(20):2379-86. PubMed ID: 25765966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination status of children aged 1-4 years in Afghanistan and associated factors, 2015.
    Shenton LM; Wagner AL; Carlson BF; Mubarak MY; Boulton ML
    Vaccine; 2018 Aug; 36(34):5141-5149. PubMed ID: 30026033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical and nursing students with suboptimal protective immunity against vaccine-preventable diseases.
    Pavlopoulou ID; Daikos GL; Tzivaras A; Bozas E; Kosmidis C; Tsoumakas C; Theodoridou M
    Infect Control Hosp Epidemiol; 2009 Oct; 30(10):1006-11. PubMed ID: 19708792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization status of internationally adopted children in Italy.
    Viviano E; Cataldo F; Accomando S; Firenze A; Valenti RM; Romano N
    Vaccine; 2006 May; 24(19):4138-43. PubMed ID: 16545505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Seroprevalence of pertussis toxin antibody in Manisa province of Turkey, after six years implementation of acellular pertussis vaccine].
    Özbek ÖA; Öktem İMA; Hekimoğlu CH; Sekreter Ö; Emek M; Atasoylu G; Açıkgöz A; Demirpençe N; Ceylan A; Baykal ES; Ünal B
    Mikrobiyol Bul; 2018 Apr; 52(2):180-189. PubMed ID: 29933735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2017.
    Walker TY; Elam-Evans LD; Yankey D; Markowitz LE; Williams CL; Mbaeyi SA; Fredua B; Stokley S
    MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(33):909-917. PubMed ID: 30138305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.